©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 110406
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110406
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110406
Table 5 Univariate logistic regression analysis of Zhejiang University index in type 2 diabetes mellitus patients
| Variables | β | SE | Z | P value | OR (95%CI) |
| Sex (female) | 0.31 | 0.16 | 1.88 | 0.06 | 1.36 (0.99-1.87) |
| Smoking | 0.17 | 0.16 | 1.05 | 0.295 | 1.18 (0.87-1.61) |
| Drinking | 0.48 | 0.16 | 3.05 | 0.002 | 1.62 (1.19-2.20) |
| Hypertension | -0.06 | 0.15 | -0.39 | 0.7 | 0.94 (0.70-1.27) |
| CAD | -0.89 | 0.27 | -3.33 | < 0.001 | 0.41 (0.24-0.69) |
| MASLD | 1.15 | 0.16 | 7.22 | < 0.001 | 3.15 (2.31-4.30) |
| Age (years) | -0.04 | 0.01 | -6.52 | < 0.001 | 0.96 (0.94-0.97) |
| BMI (kg/m2) | 0.46 | 0.04 | 11.61 | < 0.001 | 1.58 (1.46-1.71) |
| SBP (mmHg) | 0.01 | 0 | 2.06 | 0.039 | 1.01 (1.01-1.02) |
| DBP (mmHg) | 0.05 | 0.01 | 6.35 | < 0.001 | 1.05 (1.03-1.06) |
| HbA1c (%) | 0.29 | 0.04 | 7.47 | < 0.001 | 1.34 (1.24-1.45) |
| WBC (× 109/L) | 0.16 | 0.05 | 3.24 | 0.001 | 1.17 (1.06-1.29) |
| RBC (× 1012/L) | 0 | 0.01 | 0.17 | 0.864 | 1.00 (0.98-1.02) |
| PLT (× 109/L) | 0.01 | 0 | 2.29 | 0.022 | 1.01 (1.01-1.01) |
| TP (g/L) | 0.09 | 0.02 | 6.32 | < 0.001 | 1.10 (1.07-1.13) |
| ALT (U/L) | 0.04 | 0.01 | 6.85 | < 0.001 | 1.04 (1.03-1.05) |
| AST (U/L) | 0.01 | 0.01 | 2.63 | 0.008 | 1.01 (1.01-1.02) |
| BUN (mmol/L) | -0.06 | 0.03 | -1.74 | 0.081 | 0.94 (0.88-1.01) |
| Scr (mmol/L) | 0 | 0 | 0.07 | 0.947 | 1.00 (1.00-1.00) |
| UA (mmol/L) | 0.01 | 0 | 4.71 | < 0.001 | 1.01 (1.01-1.01) |
| TC (mmol/L) | 0.57 | 0.07 | 7.72 | < 0.001 | 1.77 (1.53-2.05) |
| TG (mmol/L) | 0.92 | 0.1 | 9.6 | < 0.001 | 2.51 (2.08-3.03) |
| HDL-C (mmol/L) | -0.54 | 0.27 | -2.01 | 0.045 | 0.58 (0.34-0.99) |
| LDL-C (mmol/L) | 0.56 | 0.09 | 6.06 | < 0.001 | 1.74 (1.46-2.09) |
| FBG (mmol/L) | 0.53 | 0.04 | 11.92 | < 0.001 | 1.70 (1.56-1.86) |
- Citation: Tao XY, Pan TR, Zhong X, Pan XY. Association between Zhejiang University index and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus. World J Diabetes 2025; 16(10): 110406
- URL: https://www.wjgnet.com/1948-9358/full/v16/i10/110406.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i10.110406